Genome-wide identification of m6A-associated single-nucleotide polymorphisms in Parkinson' s disease
Genome-wide identification of m6A-associated single-nucleotide polymorphisms in Parkinson' s disease
复制标题
帕金森病 m(6)A 相关单核苷酸多态性的全基因组鉴定。
DOI:
10.1016/j.neulet.2020.135315
复制
发表时间:
2020-10-15
影响因子:
2.5
通讯作者:
Xiao, Yousheng
中科院分区:
文献类型:
--
作者:
Qiu, Xiaohui;He, Honghu;Xiao, Yousheng
N6-methyladenosine (m(6)A)-associated single nucleotide polymorphisms (SNPs) play a vital role in several neurological diseases. However, little is known about the relationship between m(6)A modification and Parkin-son's disease (PD). We investigated potential functional variants of m(6)A-SNPs from large-scale genome-wide association studies (GWAS) in PD patients. The candidate m(6)A-SNPs were further assessed by expression quantitative trait loci (eQTL) analysis and differential gene expression analysis. We identified 12 m(6)A-SNPs that were significantly associated with PD risk. Further, eQTL and expression analyses identified five of these m6ASNPs (rs75072999 of GAK, rs1378602, rs4924839 and rs8071834 of ALKBH5, and rs1033500 of C6orf10) that were associated with altered gene expression in PD. Our results suggest that m(6)A-SNPs could play a role in PD risk. Future studies are needed to confirm these PD-associated m(6)A-SNPs and elucidate their mechanisms.